NCT01939665View on ClinicalTrials.gov

PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Locally Advanced Pancreatic Carcinoma (LAPC)Non-metastasized Unresectable Pancreatic CarcinomaPancreatic Cancer
Interventions
DEVICE

"NanoKnife Irreversible electroporation (IRE)"

Tumor ablation with irreversible electroporation with the NanoKnife

Trial Locations (1)

1081 HV

VU University Medical Center, Amsterdam

All Listed Sponsors
lead

Amsterdam UMC, location VUmc

OTHER

NCT01939665 - PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma | Biotech Hunter | Biotech Hunter